Using Nonheparin Anticoagulant to Treat a Near-Fatal Case With Multiple Venous Thrombotic Lesions During ChAdOx1 nCoV-19 Vaccination-Related Vaccine-Induced Immune Thrombotic Thrombocytopenia. Issue 9 (September 2021)
- Record Type:
- Journal Article
- Title:
- Using Nonheparin Anticoagulant to Treat a Near-Fatal Case With Multiple Venous Thrombotic Lesions During ChAdOx1 nCoV-19 Vaccination-Related Vaccine-Induced Immune Thrombotic Thrombocytopenia. Issue 9 (September 2021)
- Main Title:
- Using Nonheparin Anticoagulant to Treat a Near-Fatal Case With Multiple Venous Thrombotic Lesions During ChAdOx1 nCoV-19 Vaccination-Related Vaccine-Induced Immune Thrombotic Thrombocytopenia
- Authors:
- Bersinger, Samuel
Lagarde, Kevin
Marlu, Raphael
Pernod, Gilles
Payen, Jean-Francois - Abstract:
- Abstract : OBJECTIVES: To describe the successful recovery from multiple and life-threatening venous thrombosis after ChAdOx1 nCoV-19 vaccination. DESIGN: Case report. SETTING: University Hospital. Patient: Few days after the first dose of the ChAdOx1 nCoV-19 vaccine, a 21-year-old woman experienced massive thrombosis in the deep and superficial cerebral veins together with seizures, neurologic focal deficit, and thrombocytopenia. In the neurointensive care unit, her condition worsened despite early decompressive craniectomy. She developed bilateral segmental pulmonary embolism, left hepatic, and left external iliac venous thrombosis. INTERVENTION: Argatroban (0.5–2.2 µg/kg/min) and high-dose IV immunoglobulin (1 g/kg/d for 2 consecutive days) were initiated on day 6 after admission. With these therapies, there was a gradual resolution of multiple sites of venous thrombosis, and platelet count returned to normal. The patient left the ICU with full consciousness, expressive aphasia, and right hemiparesis. CONCLUSIONS: This case of vaccine-induced immune thrombotic thrombocytopenia shows that a good outcome can be obtained even with multiple and life-threatening venous thrombotic lesions. Argatroban and high-dose IV immunoglobulin along with management of severe cerebral venous thrombosis played a major role in this epilogue. Abstract : Supplemental Digital Content is available in the text.
- Is Part Of:
- Critical care medicine. Volume 49:Issue 9(2021)
- Journal:
- Critical care medicine
- Issue:
- Volume 49:Issue 9(2021)
- Issue Display:
- Volume 49, Issue 9 (2021)
- Year:
- 2021
- Volume:
- 49
- Issue:
- 9
- Issue Sort Value:
- 2021-0049-0009-0000
- Page Start:
- Page End:
- Publication Date:
- 2021-09
- Subjects:
- argatroban -- cerebral venous thrombosis -- ChAdOx1 nCoV-19 vaccine -- hepatic venous thrombosis -- immunoglobulin -- thrombocytopenia
Critical care medicine -- Periodicals
Soins intensifs -- Périodiques
616.028 - Journal URLs:
- http://journals.lww.com/ccmjournal/Pages/default.aspx ↗
http://journals.lww.com ↗ - DOI:
- 10.1097/CCM.0000000000005105 ↗
- Languages:
- English
- ISSNs:
- 0090-3493
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3487.451000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 24933.xml